Biologically active taxane analogs and methods of treatment by oral administration
US11220512B2 · kind B2 · utility
0Cited by
4References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 15, 2020 |
| Grant date | Jan 11, 2022 |
| Priority date | — |
| Expiry date | Jul 15, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel chemical compound for use in the treatment of cancer, to compositions containing said compound, methods of manufacture and combinations with other therapeutic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.